ABSTRACT BACKGROUND: Delayed union of fractured bone is one of the main problems of orthopedics and traumatology practice. It was hypothesized that the beneficial effects of allogeneic platelet-rich plasma (PRP) would be valuable in the treatment of segmental bone defects. This study is a comparison of the effects of demineralized bone matrix (DBM) and PRP in a segmental bone defect model.
the self-repair capacity of the critically defected bone is extremely limited and this condition generally requires bone grafting for mechanical and biological enhancement. Osteoinductivity, osteoconductivity, and osteogenesis are desired properties of an optimal bone graft substitute. Autogenous bone grafts (ABG) have these features and are currently considered the "gold standard". [1] [2] [3] ABG also have advantages of being easy to harvest, economical, and non-immune. However, use of ABG has some limitations such as donor side morbidity, limited reserve, and weak mechanical properties. Allografts or xenografts have unique osteoconductive properties and rarely cause disease transmission. As a result of these limitations, synthetic bone graft substitutes are being investigated. Osteoconductive agents such as ceramics, polymers, trabecular metals, and bioactive glass have been employed to provide mechanical support for vascular and bone ingrowth. [4, 5] Osteoinductive growth factors, autogenic bone
INTRODUCTION
Bone defects caused by infection, tumor, high-energy trauma, metabolic disease or massive osteolysis due to prosthesis loosening still remain a major clinical concern. Unfortunately, marrow and mesenchymal root cells promote osteogenesis while demineralized bone matrix (DBM) and platelet-rich plasma (PRP) induce formation of progenitor cells from surrounding tissues. However, each of these substitutes has its own significant limitations and none of them meets full expectations to serve as bone substitute in instance of bone defect. [6] Both PRP and DBM are osteoinductive substitutes that have been proven to yield satisfactory results for fracture healing. [1] [2] [3] [7] [8] [9] [10] [11] [12] [13] [14] A number of growth and differentiation factors are liberated, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), insulin-like growth factor-1 (IGF-1), hepatocyte growth factor, platelet factor-4, fibroblast growth factor (FGF), trombospondin-1, osteonectin, and fibronectin via activation of platelets. [15] These factors play an imperative role in intracellular signaling pathways, initiating the production of ultimate proteins essential for cellular proliferation, matrix formation, osteoid production, and the collagen synthesis involved in fracture healing. [16] [17] [18] [19] [20] [21] [22] DBM is an organic collagen matrix that includes various types of bone morphogenetic proteins (BMP), which are responsible for its osteoinductive properties. This BMP-rich matrix modulates the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. [23, 24] PRP can be prepared easily with 2-step centrifugation of autogenous blood, and DBM can be obtained commercially.
Positive impacts of PRP and DBM alone and in combination with other substitutes are well documented, but no assessment has been made as yet of a combination of PRP and DBM on healing of long bone defects. Based on these findings, the present study evaluated the impact of individual and combined applications of PRP and DBM on fracture healing of critical bone defects. It was hypothesized that allogeneic PRP would have beneficial effect on treatment of segmental bone defects, comparable to DBM. Possibility of agonistic or additive osteoinductive effects of DBM and PRP combination was also investigated.
MATERIALS AND METHODS

Animals and Surgical Procedure
This experimental study was conducted at Bülent Ecevit University (Zonguldak, Turkey) animal research laboratories, after receiving the approval of the ethics committee for animal research (1564-2599-2011/21). Forty-eight, 9-month-old, male, inbred Wistar albino rats with an average weight of 350 g were used in this study. Twelve rats of similar age and weight were used for PRP preparation. Prior to surgical creation of bone defects, all animals were allowed to acclimate to the laboratory environment for a period of 10 days. All rats were kept in plastic cages with access to food and water ad libidum and screened for common disease. Rats were maintained at 22°C±-2°C environmental temperature in 12 hours light and 12 hours darkness cycle. None of the rats had been subjected to any experiments prior to this study. The rats were randomly divided into 4 groups:
Twenty-four hour before surgical procedure, the animals were fasted. A single dose of Iespor (cephazoline sodium, 20 mg/kg; Ibrahim Ethem Ulugay İlaç Sanayi Türk A.Ş., İstanbul, Turkey) was administered to all animals preoperatively. All rats were anesthetized with 50 mg/kg of ketamine hydrochloride (Ketalar; Pfizer Inc., NY, NY, USA), injected intraperitoneally, prior to surgery. [25] Anesthesia was monitored and maintained by a veterinarian during all phases of surgical procedure. Rats were placed in right decubitus and left forearm was shaved. Bone defect of approximately 10-mm (twice the radius of radii) was created in midshaft of the radius with a sharp rib bone knife. Osteotomy site was then irrigated with 0.9% saline, but no attempt was made to resect the periosteum around osteotomy site as this had been retracted with the overlying muscles. Osteotomy site was treated following the protocol for each group. As only the radius had been osteotomized, no fixation was employed, and the animals were able to use both extremities effectively. [26] [27] [28] Bone defects in Group 3 (DBM) and Group 4 (DBM+PRP) were filled with approximately 0.3 cc injectable DBM (Ultra DBM Matrix; TissueNet, Inc., Orlando, FL, USA). Immediately after surgery, while rats were still under anesthesia, roentgenograms of the limbs were taken. Fifteen mg/kg of tramadol (Ultramex, Adeka İlaç Kimyasal Ürünler Sanayi ve Ticaret A.Ş., Istanbul, Turkey) was used for postoperative analgesia. Rats were then put into separate cages with no restriction of activities. Parizi et al. proposed that if PRP was injected intraoperatively during the surgical operation, inflammatory agents could destroy the injected PRP and render it potentially ineffective in later stages of healing.
[29] Therefore 1 mL of allogeneic PRP was injected percutaneously into bone defects in Group 2 and Group 3 on postoperative third day.
Allogeneic PRP Preparation
Four rats per 12 experimental animals (12 exsanguination animals total) were anesthetized with 50 mg/kg of ketamine hydrochloride (Ketalar; Pfizer Inc., NY, NY, USA), injected intraperitoneally, prior to blood collection via intracardiac aspiration after sternotomy. capped monovette containing 3.2% sodium citrate (0.5 mL), approximately 30 minutes before injection. Monovette was centrifuged at 1800 rpm for 10 minutes. [16, 19] After first centrifugation, 2 layers were clearly visible in monovette. Upper yellow layer consisted of platelet-rich and platelet-poor plasma, while lower red layer consisted of erythrocytes and leukocytes, as has previously been documented. [30] Lower red layer has been reported to be rich in platelets that recently entered the circulation. [31, 32] Total plasma consisting of complete upper yellow layer and top 1 to 2 mm of lower red layer was transferred to sterile monovette. After second centrifugation at 4000 rpm for 7 minutes, approximately 0.7 mm at the bottom of the monovette was platelet-rich plasma and upper portion was mostly platelet-poor plasma. [30] Supernatant platelet-poor plasma was collected and removed by pipette. Remaining platelet-rich plasma was then carefully transferred into application injector.
Radiological Analysis
After 10 weeks of healing, rats were sacrificed and upper extremities were removed from the corpus in order to obtain optimal anterior-posterior X-ray images. Two orthopedic surgeons who were blinded to group assignments but informed about evaluation method performed radiological assessments. These 2 surgeons were not involved in the present study. Results were scored using the grading scale described by Cook et al. (Table 1 ).
[33]
Histological and Histomorphometrical Analysis
Whole specimens were initially fixed in 10% formaldehyde for 2 weeks. During subsequent 2 weeks, samples were placed in 10% ethylenediaminetetraacetic acid solution for decalcification process. Samples were than embedded in paraffin blocks and 5 µm-thick sections were cut through long axis from fractured zone and stained with hematoxylin and eosin for routine light microscope analysis. [34] Pathologist who was blinded to groups and experimental procedure evaluated the specimens with 14-point histological grading scale described by Salkeld et al. (Table 2 ) to determine quality of union, appearance and quality of cortical and cancellous bone remodeling, and degree of bone graft incorporation and remodeling. [35] Statistical Analysis 
RESULTS
One rat from control group did not wake from anesthesia, so total of 47 completed the experiment without major wound or other complication. These 47 rats were sacrificed for radiological and histological assessments. Table 3 summarizes radiological evaluation results. In radiological assessment of healing, there were significant differences between control group and PRP group, and PRP group and PRP+DBM combination group, in favor of PRP group (p=0.007). There was no significant difference between control group and PRP+DBM combination group (p=0.354). No obvious cortical bridging was denoted in either control or PRP+DBM groups. There was significant difference between control group and DBM group (p<0.001). There was also significant difference between DBM group and PRP+DBM combination group. PRP group achieved higher scores in radiological assessment. Radiological data also indicated that control group and PRP/DBM combination group displayed similar level of radiological healing (Figure 1a-d) . 
Radiological Findings
Histopathological Findings
Histopathological evaluation was based on the following parameters: 1) quality of union, 2) cortical development and remodeling, and 3) new bone formation.
There was a significant difference between control group and PRP group in terms of quality of union (p<0.001). Endochondral ossification in defect site was most clearly seen in PRP group. There was significant difference between control group and PRP+DBM combination group, while no difference was found between PRP group and DBM group (p=768). There was significant difference between control group and DBM group (p<0.001): fibrous union was greatest in control group. There was no significant difference between PRP group and PRP+DBM combination group (p=0.456). Although Salkeld scores were slightly higher in PRP+DBM combination group, there was no statistically significant difference between combination group and DBM group (p=0.874).
Significant difference was found between PRP group and PRP+DBM group in terms of cortical development and remodeling that favored PRP group (p<0.001). There was also statistically significant difference between the PRP+DBM combination group and DBM group, with greater healing seen in DBM group (p=0.010). In addition, there was significant difference found between control group and PRP group (p<0.001). There was no significant difference between control group and PRP+DBM group (p=0.624). Cortex development remodeling was significantly superior in DBM group than control group (p<0.001). No significant difference was determined between PRP group and DBM group (p=0.323).
In terms of new bone formation, rats in control group had significantly lower scores compared with PRP, PRP+DBM combination, and DBM groups (p=0.334), and there was no significant difference between the experiment groups (p=0.063). Summary of histopathological findings is provided in Table 4 . Significant microscopic findings of the groups are provided in Figure 2a 
DISCUSSION
Segmental bone defects continue to be a major problem in the practice of orthopedics and traumatology. There is still no universally accepted treatment standard for this problem. The current therapies are disputable in terms of morbidity and cost/benefit ratio, and it is obvious that new approaches are required. The present study evaluated effects of PRP application to healing of segmental bone defects, what we consider to be a new approach in the treatment of segmental bone defects.
This research demonstrated that PRP is as efficient as DBM based on radiological and histopathological evidence of healing in segmental bone defects; however, same effects were not observed with the combined use of PRP and DBM.
For many years, researchers working with bone tissue have been investigating methods and bone grafts that would accelerate fracture healing and promote rapid recovery of bone defects or that could be used in the reconstruction of larger defects to achieve union and filling of the defect with fewer complications. Although there was success in these studies, these methods are not commonly used in clinical practice. [1, 2, [4] [5] [6] It was realized that bone metabolism is regulated through various chemical and metabolic pathways, and that certain peptides (growth factors) are released from platelets, macrophages, and fibroblasts during the union of fractures. These proteins are known to organize delicate processes such as proliferation, differentiation, migration, and resorption in the healing of fractures. Studies have focused on the production of these growth factors with recent advances in recombinant gene technology. The main focus of these studies has been BMPs from the TGF family, and TGF-β, PDGF, VEGF, FGF, and IGF have been shown to have favorable effects on bone healing. Experimental studies have demonstrated the favorable effects of these molecules on bone healing; however, these substances have not been introduced into clinical practice due to high costs of recombinant gene technology. [36] [37] [38] Many growth factors including PDGF, VEGF, TGF β1-2, and FGF are deposited in the granules of circulating platelets, and these substances are released in response to various stimulations. [39] In light of these data, the present study aimed to extract these growth factors by centrifugation of allogeneic venous blood in order to reduce the costs. PRP suspension prepared from venous blood contains many growth factors as well as fibrinogen, and application to fracture site allows direct activity to occur.
Experimental studies with PRP are required before the introduction of PRP into clinical practice due to the fact that available studies either lack control groups or they are insufficient. Among these limited studies, Marx et al. compared autologous bone graft alone with autologous bone graft plus PRP application and noted an increase in bone formation and bone density, which they attributed to PDGF and TGF-β. [18, [40] [41] [42] Anitua et al. injected PRP into empty cavity after tooth extraction and reported an increase in both epithelialization and bone density. [9] Aghaloo and Butterfield study of bone grafts and PRP application failed to show superiority of PRP; however, there are also studies showing accelerated advancement of bone tissue when PRP is used with the grafts used in dentistry for osteointegration, and there are also reports on successful outcomes in maxillary arthroplasty. [8, 32, 43] Ulus Travma Acil Cerrahi Derg, March 2017, Vol. 23 PRP has been used together with autograft and hydroxyapatite in patients undergoing lumbar spinal fusion, and both favorable and unfavorable outcomes have been reported. [44, 45] Siebrecht et al. showed that PRP increased tissue ingrowth and ossification inside porous hydroxyapatite, and they also reported increased tensile strength and callus of Achilles tendon of rats after PRP application. [42] Use of plasma-rich plasma was recommended in arthroscopic surgery after demonstration of favorable effects on ligaments. [36] Nagata et al. compared autograft and autograft-PRP combination after creating critically large calvarial bone defect in rabbits, and they noted significantly faster ossification at 4 weeks in the autograft-PRP group; however, outcomes at 12 weeks were similar in the 2 groups. [45] Cheng et al. evaluated outcomes of PRP, autograft, and PRP-bone marrow-derived stromal cell mixture on critically large calvarial bone defect in rabbits, and reported minimum repair in PRP group and significantly higher new bone formation in bone marrow-derived stromal cell plus PRP group. [46] Gumieiro et al. compared PRP and control groups using monocortical defect model in irradiated rat tibia and reported statistically significant outcomes in terms of ossification. [47] In the present study we also questioned the possibility of agonistic effects of DBM and PRP on fracture healing. DBM was selected for its osteoinductive effects based on BMPs, while PRP lacks these proteins. Our study revealed that both PRP and DBM had favorable effects on fracture healing when applied separately, but combination of these methods did not provide additional benefits. This finding was also supported by a study conducted by Ranly et al. on athymic rats in which DBM embedded in gastrocnemius muscle was combined with PRP that was and was not activated by thrombin, and ossification was evaluated at days 14, 28, and 56 after application. [48] Combination of PRP and DBM did not display any additional benefits to condrogenesis over DBM alone at day 14; however, the combination was associated with induction of osteogenesis and higher production of new bone islets and new bone formation at days 28 and 56. On the other hand, thrombin-activated PRP had inhibitor effect on DBM and inhibited both condrogenesis and osteogenesis. In our study, PRP was kept in citrated tubes after preparation and activated with citrate. In a study conducted by BoHan et al., combination of DBM and PRP was implanted in muscle tissue to examine ectopic bone formation within the connective tissue. PRP produces different responses in different tissue. Their study evaluated the fracture healing process when PRP was used alone and in combination with DBM.They concluded that PRP significantly increased in vivo DBM osteoinductivity only when used without thrombin activation. [49] In the present study we demonstrated that citrate-activated PRP can also inhibit osteoinductive effect of DBM.
In another study by Ranly et al. in immunosuppressed rats, implants prepared with DBM and various doses of PRP were inserted into leg muscles of rats, and they evaluated osteoinduction, new bone and cartilage formation, and if PRP and implanted DBM played a modulator role in osteoinduction by dissecting the tissue at days 14, 28, and 56.
[50] The examination at day 14 showed that amount of cartilage decreased with increasing PRP doses, and in addition, dissection performed at days 28 and 56 showed that PRP delayed new bone formation and resorption of the graft in a dose-dependent manner. In their study, both PRP and DBM were found to be effective in the healing of fractures; however, combined use of these substances did not have additional benefit over single use. This study evaluated new bone formation inside muscle tissue and not new bone formation in the fracture line. PRP results are different in each model, and exogenous PRP applied to the fracture line may accelerate the healing of fracture together with other osteogenic proteins. PRP applied in the present study was released from implants in the early inflammatory phase of osteoinduction in the soft tissue, whereas later application of PRP to the fracture site induces PRP production from the osteoblasts as if it were a paracrine factor. Due to technical difficulties the dose of PRP was not adjusted in our study, and the response to the healing of segmental defect was evaluated after application of PRP to the bone defect One of the limitations of our study was that dose standardization for PRP and DBM was not possible due to technical drawbacks. This study evaluated 2 phases, namely the initial and final phases, and interim phases were not evaluated. In addition, biomechanical studies regarded as optimal for evaluating the healing of fractures were not appropriate in rat bone defect model and therefore could not be performed. In this study, withdrawal of autologous blood from each rat for PRP preparation was not feasible because of the risk of sample loss due to blood collection, and therefore, PRP was prepared from blood withdrawn from 4 other rats though intracardiac route at the beginning of the study and allogeneic PRP was used. Burhoe and Moore demonstrated that there are subgroups of blood in rats, although there is no blood type; however, this was not taken into consideration due to the fact that these subgroups do not exhibit immunogenicity against each other. [51, 52] 
Conclusion
Radiological and histological assessment in this study revealed similar results for PRP and DBM, and the combination of these 2 did not provide additional benefits. As an autologous product, absence of any risk for the transmission of infection, absence of allergic reactions, easy preparation in the operating room, and lack of additional costs can be regarded as advantages of PRP over commercial DBM products.
The present study was an experimental animal study, and our literature search revealed that this was the first study to eval-uate use of PRP and DBM combination in bone tissue. PRP is currently used in muscle-tendon injuries and similar studies can guide future prospects for the use of PRP to accelerate healing in segmental bone defects.
This research demonstrated that PRP is as efficient as DBM in the treatment of segmental bone defects, and similar results in in vivo tests and biomechanical studies may lead to the introduction of PRP therapy to clinical practice in the treatment of segmental bone defects.
